C. Coyle

945 citations
13 papers · 637 indexed · 1 hit paper · h-index 7

C. Coyle

12 papers receiving 631 citations

Hit Papers

Metformin as an adjuvant treatment for cancer: a systemat...3372016202620192022100200300

Peers

C. Coyle
Comparison fields: 5 of 77
  • Cancer Research 186
  • Oncology 306
  • Reproductive Medicine 40
  • Pharmacology 80
  • Molecular Biology 290
Replace N.J. Bundred with:
N.J. Bundred United Kingdom
Lijin Feng China
D. G. Kieback Germany
Sang‐Ah Han South Korea
O Abe Japan
Nazan Günel Türkiye
Olga Ace Canada
José E. Alés‐Martínez Spain
Sara Margolin Sweden
Robert S. de Jong Netherlands
C. Coyle relative to N.J. Bundred United Kingdom N.J. Bundred's profile →
Citations per field
00.5×8.2×
N.J. Bundred · 1×
Citations per year

Countries citing papers authored by C. Coyle

Since Specialization
Citations

This map shows the geographic impact of C. Coyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Coyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Coyle more than expected).

Fields of papers citing papers by C. Coyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Coyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Coyle. The network helps show where C. Coyle may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Coyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Coyle Line = papers co-authored together C. Coyle links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20241
2 20201
3 20177
4 201738
5
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysisbreakdown →
2016337
6 20160
7 201644
8 2016116
9 20151
10 201382
11 20138
12 20121
13 19601

About C. Coyle

C. Coyle is a scholar working on Reproductive Medicine, Critical Care and Intensive Care Medicine and Oncology, having authored 13 papers that have together received 637 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Global Cancer Incidence and Screening (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Inflammatory mediators and NSAID effects (2 papers), Advanced Breast Cancer Therapies (1 paper), Biomedical Ethics and Regulation (1 paper), Cancer Risks and Factors (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Cancer Research (186 citations), Oncology (306 citations) and Reproductive Medicine (40 citations). C. Coyle has collaborated with scholars based in United Kingdom, Australia and Mexico. Frequent co-authors include Ruth E. Langley, Fay Cafferty, Claire L. Vale, Mark Bower, Alistair Ring, Victoria Tittle, Mark Nelson, Alessia Dalla Pria, Lindy Berkman and Sudeep Gupta. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Contemporary Clinical Trials, Journal of Geriatric Oncology and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026